These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Podophyllin office therapy against condyloma should be abandoned.
    Author: von Krogh G, Longstaff E.
    Journal: Sex Transm Infect; 2001 Dec; 77(6):409-12. PubMed ID: 11714936.
    Abstract:
    Podophyllin, a crude plant extract with low efficacy, high toxicity, and a serious mutagenicity profile does not comply with the WHO guidelines for plant derived treatments and should be removed from clinical treatment protocols. Home treatment with pharmaceutical products based on podophyllotoxin-the purified, standardised active antiwart ingredient of podophyllin-represents safe and effective first line therapy for patients with anogenital warts.
    [Abstract] [Full Text] [Related] [New Search]